| 000 | 01813 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513151139.0 | ||
| 264 | 0 | _c19980826 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(97)10109-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStahl, M | |
| 245 | 0 | 0 |
_aPre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cApr 1998 |
||
| 300 |
_a668-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntidotes _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xmethods |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aEsophagogastric Junction |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPreoperative Care _xmethods |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVanhoefer, U | |
| 700 | 1 | _aStuschke, M | |
| 700 | 1 | _aWalz, M K | |
| 700 | 1 | _aMüller, C | |
| 700 | 1 | _aWilke, H | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 34 _gno. 5 _gp. 668-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(97)10109-5 _zAvailable from publisher's website |
| 999 |
_c9678780 _d9678780 |
||